Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P48984

Entry ID Method Resolution Chain Position Source
AF-P48984-F1 Predicted AlphaFoldDB

No variants for P48984

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P48984

No associated diseases with P48984

2 regional properties for P48984

Type Name Position InterPro Accession
domain TEA/ATTS domain 26 - 104 IPR000818
domain YAP binding domain 226 - 435 IPR041086

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
transcription regulator complex A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.

2 GO annotations of molecular function

Name Definition
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.

3 GO annotations of biological process

Name Definition
embryonic organ development Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
hippo signaling The series of molecular signals mediated by the serine/threonine kinase Hippo or one of its orthologs. In Drosophila, Hippo in complex with the scaffold protein Salvador (Sav), phosphorylates and activates Warts (Wts), which in turn phosphorylates and inactivates the Yorkie (Yki) transcriptional activator. The core fly components hippo, sav, wts and mats are conserved in mammals as STK4/3 (MST1/2), SAV1/WW45, LATS1/2 and MOB1.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q15561 TEAD4 Transcriptional enhancer factor TEF-3 Homo sapiens (Human) PR
Q62296 Tead4 Transcriptional enhancer factor TEF-3 Mus musculus (Mouse) PR
10 20 30 40 50 60
MTSEWSSPAS PEGSNDSGGS EALDKPIDND AEGVWSPDIE QSFQEALAIY PPCGRRKIIL
70 80 90 100 110 120
SDEGKMYGRN ELIARYIKLR TGKTRTRKQV SSHIQVLARR KAREIQAKLK KTQVDKYDFS
130 140 150 160 170 180
SEKDQTAKDK AMQSIATMSS AQIISATAFH SKMALPGLPR SAYPAVSGFW QGALPGQAGS
190 200 210 220 230 240
SQDVKPFTQQ PYALQPSLPL PGFDSPTGLP PSSSTPAWQG RRVASSKLWM LEFSAFLEQQ
250 260 270 280 290 300
QDQDTYNKHL FVHIGQSNPS YSDPYLEAVD IRQIYDKFPE KKGGLKELFE RGPANAFFLV
310 320 330 340 350 360
KFWADLNTNI EDESRSFYGV SSQYESPENM VITCSTKVCS FGKQVVEKVE TEYAHYENGH
370 380 390 400 410 420
YAYRIHRSPL CEYMINFIHK LKHLPEKYMM NSVLENFTIL QVVTNRDTQE TLLCIAYVFE
430
VSASDHGAQH HIYRLVKD